hoxd9a Antibody

What is HOXD9A and what is its significance in developmental biology research?

HOXD9A belongs to the homeobox gene family, which are critical developmental regulatory proteins that provide cells with specific positional identities on the anterior-posterior axis. Studies have shown that HOXD9 plays crucial roles in limb development and morphogenesis. In particular, deletion of the Hoxd9a structural domain can lead to disruptions in protein translation and pelvic fin localization in certain species such as P. argenteus . HOXD9 is part of a regulatory system essential for proper embryonic development and patterning, making it a significant target for developmental biology research.

What are the standard applications for HOXD9 antibodies in research settings?

HOXD9 antibodies are primarily used in the following applications:

These applications allow researchers to detect endogenous HOXD9 protein with high sensitivity . While not specifically for HOXD9A, comparable HOX antibodies such as HOXA9 are also frequently used in Immunohistochemistry (IHC) at dilutions of 1:500-1:2000 and ChIP applications for studying DNA-protein interactions .

What species reactivity can be expected from commercial HOXD9 antibodies?

Commercial HOXD9 antibodies typically show reactivity with human and non-human primate (e.g., monkey) samples . When selecting an antibody for your research, it's important to verify species cross-reactivity in the product documentation. For example, the Cell Signaling Technology HOXD9 antibody (#62883) specifically indicates reactivity with human and monkey samples, with a molecular weight of approximately 42 kDa . If working with other species like mouse or fish models, custom antibody production may be necessary, as was done for P. argenteus Hoxd9a studies .

What is the recommended protocol for using HOXD9 antibodies in Western Blotting?

For optimal Western Blotting results with HOXD9 antibodies:

• Prepare protein samples from relevant tissues or cell lines

• Separate proteins using SDS-PAGE

• Transfer proteins to a membrane (PVDF or nitrocellulose)

• Block with 5% non-fat dry milk in TBST or similar blocking buffer

• Incubate with primary HOXD9 antibody at 1:1000 dilution overnight at 4°C

• Wash membrane 3-5 times with TBST

• Incubate with appropriate HRP-conjugated secondary antibody

• Develop using chemiluminescence detection

The expected molecular weight for HOXD9 is approximately 42 kDa . For comparable HOX family members like HOXA9, the calculated molecular weight is 30 kDa, but the observed molecular weight is typically around 40 kDa due to post-translational modifications . It is recommended to titrate the antibody in each testing system to obtain optimal results.

How should I design primers for qPCR analysis of Hoxd9a expression?

When designing primers for qPCR analysis of Hoxd9a expression:

• First identify the core sequence of the Hoxd9a gene in your species of interest

• Design primers that specifically amplify Hoxd9a regions without cross-reactivity to other HOX genes

• Ensure primer pairs span exon-exon junctions where possible to prevent genomic DNA amplification

• Validate primer specificity using in silico tools and experimental validation

• Use a reference gene (e.g., 18S rRNA) as an internal control

For example, in P. argenteus studies, researchers designed primers (qHoxd9a-F1 and qHoxd9a-R1) based on the full-length Hoxd9a sequence, and used 18S rRNA as the internal reference gene . The qPCR reaction protocol typically involves pre-denaturation at 95°C for 10 minutes, followed by 35 cycles of 95°C for 15 seconds, 60°C for 1 minute, and 72°C for 25 seconds.

What are the optimal storage conditions for HOXD9 antibodies to maintain reactivity?

To maintain antibody activity and stability:

• Store antibodies at -20°C when not in use

• Most commercial HOXD9 antibodies are stable for at least one year after shipment when properly stored

• Avoid repeated freeze-thaw cycles by preparing working aliquots

• Some antibody preparations contain stabilizers such as glycerol and BSA

For instance, comparable HOX antibodies are typically stored in PBS with 0.02% sodium azide and 50% glycerol at pH 7.3, and remain stable for one year when stored at -20°C . Small aliquots (e.g., 20μl) may contain 0.1% BSA as a stabilizer. Always refer to the manufacturer's instructions for specific storage recommendations.

How can I validate the specificity of a HOXD9 antibody for my experimental system?

To validate HOXD9 antibody specificity:

• Positive and negative controls: Include tissues/cell lines known to express or not express HOXD9

• Blocking peptide competition: Pre-incubate antibody with the immunizing peptide to confirm specificity

• Knockdown/knockout validation: Use siRNA, shRNA, or CRISPR to reduce HOXD9 expression and confirm reduced antibody signal

• Multiple antibody comparison: Test multiple antibodies against different HOXD9 epitopes

• Cross-reactivity testing: Test against other HOX proteins, particularly closely related family members

For example, HOXD9 antibody validation could include western blot analysis comparing cell lines with known HOXD9 expression patterns . Additionally, immunofluorescence studies with HOXD9 antibodies can be validated by comparing staining patterns with in situ hybridization results, as was done for Hoxd9a in P. argenteus larvae and juveniles .

What controls should I include when performing immunofluorescence with HOXD9A antibodies?

When conducting immunofluorescence with HOXD9A antibodies, include the following controls:

• Primary antibody omission: To assess background from secondary antibody

• Isotype control: Using non-specific IgG from same species as primary antibody

• Blocking peptide competition: To confirm binding specificity

• Positive tissue control: Sample known to express HOXD9A

• Negative tissue control: Sample known not to express HOXD9A

• Secondary antibody alone control: To assess non-specific binding

For Hoxd9a immunofluorescence in fish larvae and juveniles, researchers first produced recombinant Hoxd9a protein via prokaryotic expression, immunized rabbits to obtain antibodies, and then used these antibodies for immunofluorescence localization studies . This approach ensures specificity through custom antibody production targeted to the exact protein of interest.

Why might I observe multiple bands in Western blot when using HOXD9 antibodies?

Multiple bands in HOXD9 Western blots may occur for several reasons:

• Post-translational modifications: Phosphorylation, methylation, or other modifications can alter protein migration

• Protein isoforms: Alternative splicing may generate different HOXD9 isoforms

• Protein degradation: Partial proteolysis during sample preparation

• Cross-reactivity: Antibody binding to related HOX proteins

• Non-specific binding: Insufficient blocking or high antibody concentration

To address multiple bands:

• Include protease inhibitors in sample preparation

• Optimize antibody dilution (typically 1:1000 for WB)

• Increase blocking stringency

• Use freshly prepared samples

• Consider using different lysis buffers

Note that even with optimized conditions, HOX proteins may sometimes appear at slightly different molecular weights than calculated. For example, HOXA9 has a calculated molecular weight of 30 kDa but is typically observed at 40 kDa in Western blots .

How can I improve signal-to-noise ratio in HOXD9 immunostaining experiments?

To improve signal-to-noise ratio in HOXD9 immunostaining:

• Optimize antibody dilution: Test a range of dilutions to find optimal concentration

• Improve blocking: Use 5% normal serum from the species of the secondary antibody

• Antigen retrieval optimization: Test multiple methods (heat-induced, enzymatic, pH variations)

• Increase washing steps: More thorough washing with agitation

• Reduce autofluorescence: Use Sudan Black or commercial autofluorescence reducers

• Use more specific detection systems: Consider tyramide signal amplification for weak signals

For immunohistochemistry with comparable HOX antibodies, researchers often use antigen retrieval with TE buffer at pH 9.0 or citrate buffer at pH 6.0 . The recommended dilution range for IHC is typically 1:500-1:2000, but this should be optimized for each experimental system.

How can HOXD9 antibodies be used to study protein-DNA interactions through ChIP assays?

For Chromatin Immunoprecipitation (ChIP) using HOXD9 antibodies:

• Cross-linking: Fix cells with formaldehyde to create protein-DNA crosslinks

• Chromatin preparation: Lyse cells and shear chromatin by sonication to 200-500bp fragments

• Immunoprecipitation: Use HOXD9 antibody (typically 2-5μg) to pull down HOXD9-bound DNA

• Washing and elution: Remove non-specific interactions and elute HOXD9-DNA complexes

• Reverse cross-linking: Break protein-DNA crosslinks

• DNA purification and analysis: Purify DNA for qPCR, sequencing, or microarray analysis

HOX antibodies have been successfully used in ChIP applications to identify binding sites within the genome . When designing ChIP experiments with HOXD9 antibodies, it's critical to include appropriate controls such as IgG immunoprecipitation and input chromatin. Additionally, validate recovered sequences through qPCR of known target genes before proceeding to genome-wide analyses.

What approaches can I use to study HOXD9 involvement in developmental processes?

To investigate HOXD9's role in development:

• Temporal and spatial expression analysis: Use qPCR and immunohistochemistry to map HOXD9 expression throughout development

• Functional perturbation: Apply CRISPR/Cas9, morpholinos, or dominant-negative constructs to alter HOXD9 function

• Lineage tracing: Combine HOXD9 expression with lineage markers to track cell fate

• Protein interaction studies: Use co-immunoprecipitation with HOXD9 antibodies to identify binding partners

• Transcriptional regulation analysis: Combine ChIP with RNA-seq to identify HOXD9 target genes

Researchers studying Hoxd9a in P. argenteus performed real-time PCR to detect Hoxd9a expression in 8 distinct tissues and 12 different growth periods, using 18S rRNA as an internal reference . This approach revealed tissue-specific and temporally-regulated expression patterns crucial for understanding developmental roles. Deletion of the Hoxd9a structural domain led to disruptions in protein translation and pelvic fin localization, highlighting its developmental significance .

How can HOXD9 antibodies be used to investigate potential roles in cancer research?

For cancer research applications with HOXD9 antibodies:

• Expression profiling: Compare HOXD9 levels between normal and tumor tissues using IHC and Western blot

• Prognostic marker analysis: Correlate HOXD9 expression with clinical outcomes

• Mechanistic studies: Investigate HOXD9's role in proliferation, invasion, and metastasis through knockdown/overexpression

• Drug response evaluation: Analyze how HOXD9 expression changes following treatment

• Epigenetic regulation: Study methylation status of HOXD9 in conjunction with protein expression

Several studies have linked HOX genes to cancer development and progression. For instance, HOXD9 has been investigated in context of oncology research, with studies showing altered expression in certain cancer types . The literature specifically mentions studies by Makiyama et al. (2005), Marzese et al. (2014), Sriraksa et al. (2013), and Tabuse et al. (2011) that explored HOXD9's role in cancer contexts .

How do HOXD9 and HOXA9 antibodies differ in terms of specificity and cross-reactivity?

HOXD9 and HOXA9 belong to different HOX gene clusters but share homology in their homeobox domains. When comparing their antibodies:

• Epitope differences: HOXD9 and HOXA9 antibodies target unique epitopes outside the conserved homeobox domain

• Molecular weight distinction: HOXD9 is typically detected at approximately 42 kDa , while HOXA9 is observed at around 40 kDa despite a calculated weight of 30 kDa

• Species reactivity variation: HOXD9 antibodies from Cell Signaling show reactivity with human and monkey samples , while some HOXA9 antibodies demonstrate broader reactivity including human and mouse samples

• Application optimization: Each antibody requires specific optimization for different applications

To minimize cross-reactivity concerns:

• Use antibodies raised against N-terminal regions where sequence divergence is greater

• Validate specificity with knockout/knockdown controls

• Consider peptide competition assays to confirm binding specificity

What techniques can I use to distinguish between closely related HOX proteins in my samples?

To distinguish between closely related HOX proteins:

• Highly specific antibodies: Use antibodies raised against unique regions rather than conserved homeodomains

• Sequential immunoprecipitation: Deplete one HOX protein before immunoprecipitating another

• Mass spectrometry validation: Confirm protein identity following immunoprecipitation

• Parallel knockdown studies: Selectively reduce individual HOX proteins and observe antibody signal changes

• Isoform-specific PCR: Design primers targeting unique regions to distinguish at mRNA level before protein analysis

For instance, when studying both HOXA9 and HOXD9, researchers should carefully select antibodies targeting non-conserved regions and validate specificity using overexpression or knockdown approaches. When analyzing expression patterns, consider using multiple techniques (qPCR, Western blot, IHC) to build a comprehensive picture of HOX protein expression.